Save your place

Sign in to WhoBought

Please try again later.

TransMedics Group, Inc. (TMDX) institutional ownership

Latest close $72.26 Jul 24, 2026
Market cap$4.4B 52-week range SectorHealthcare
Funds holding · Q1 2026
410
reported TMDX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net sold $95M
209 buyers · 201 sellers

TransMedics Group, Inc. (TMDX) price and institutional activity

Dates

Q1 2026

$368M bought by 209 investors
Invesco Ltd.$46MCitigroup Inc$37M +207 more
$463M sold by 201 investors
Driehaus Capital Management LLC-$88MTwo Sigma Advisers, LP-$47M +199 more
Bought Sold Totals per quarter; hover a bar for the names.

TransMedics Group, Inc. (TMDX) institutional activity · 410

Investor Type Est. change Change Δ Own Date
Driehaus Capital Management LLC · Reduced −$88M
Change −672K Date Q1 2026
Driehaus Capital Management LLC Reduced· Q1 2026 −$88M −672K Q1 2026
Two Sigma Advisers, LP · Exited −$47M
Change −362K Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −$47M −362K −100.0% Q1 2026
Invesco Ltd. · Added +$46M
Change +353K Δ Own +51.6% Date Q1 2026
Invesco Ltd. Added· Q1 2026 +$46M +353K +51.6% Q1 2026
Citigroup Inc · Added +$37M
Change +285K Date Q1 2026
Citigroup Inc Added· Q1 2026 +$37M +285K Q1 2026
T. Rowe Price Associates · Reduced −$29M
Change −223K Date Q1 2026
T. Rowe Price Associates Reduced· Q1 2026 −$29M −223K Q1 2026
Marshall Wace, LLP · Reduced −$23M
Change −175K Date Q1 2026
Marshall Wace, LLP Reduced· Q1 2026 −$23M −175K Q1 2026
Millennium Management LLC · Added +$20M
Change +157K Date Q1 2026
Millennium Management LLC Added· Q1 2026 +$20M +157K Q1 2026
Capital World Investors · Added +$19M
Change +147K Date Q1 2026
Capital World Investors Added· Q1 2026 +$19M +147K Q1 2026
Susquehanna International Group, LLP · New +$17M
Change +134K Date Q1 2026
Susquehanna International Group, LLP New· Q1 2026 +$17M +134K Q1 2026
Exoduspoint Capital Management, LP · New +$15M
Change +115K Date Q1 2026
Exoduspoint Capital Management, LP New· Q1 2026 +$15M +115K Q1 2026
Two Sigma Investments, LP · Reduced −$14M
Change −111K Δ Own −25.4% Date Q1 2026
Two Sigma Investments, LP Reduced· Q1 2026 −$14M −111K −25.4% Q1 2026
State of Michigan Retirement System · Exited −$14M
Change −108K Δ Own −100.0% Date Q1 2026
State of Michigan Retirement System Exited· Q1 2026 −$14M −108K −100.0% Q1 2026
Squarepoint Ops LLC · Reduced −$13M
Change −103K Date Q1 2026
Squarepoint Ops LLC Reduced· Q1 2026 −$13M −103K Q1 2026
BlackRock · Reduced −$13M
Change −102K Date Q1 2026
BlackRock Reduced· Q1 2026 −$13M −102K Q1 2026
Goldman Sachs Group Inc · Reduced −$13M
Change −100K Date Q1 2026
Goldman Sachs Group Inc Reduced· Q1 2026 −$13M −100K Q1 2026
Data through Q1 2026 · filed Jun 11, 2026
15 of 410

Famous investor activity in TransMedics Group, Inc. (TMDX)

TransMedics Group, Inc. (TMDX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Corcoran Nicholas · Officer 2 operations 30K
Owned 18K Trade date Jul 10, 2026 Filed date Jul 14, 2026
Corcoran Nicholas Officer 2 operations 30K 18K Jul 10, 2026 Jul 14, 2026
Hernandez Gerardo · Officer 2 operations 43K
Owned 26K Trade date Jul 10, 2026 Filed date Jul 14, 2026
Hernandez Gerardo Officer 2 operations 43K 26K Jul 10, 2026 Jul 14, 2026
Hassanein Waleed H. · Director 2 operations 163K
Owned 113K Trade date Jul 10, 2026 Filed date Jul 14, 2026
Hassanein Waleed H. Director 2 operations 163K 113K Jul 10, 2026 Jul 14, 2026
Gunderson Thomas J. · Director Sell −$722K
Price $75.06 Qty −10K Owned 17K Trade date Jun 15, 2026 Filed date Jun 17, 2026
Gunderson Thomas J. Director Sell $75.06 −10K −$722K 17K Jun 15, 2026 Jun 17, 2026
Gunderson Thomas J. · Director 2 operations 0
Price $2.21 Owned 0 Trade date Jun 15, 2026 Filed date Jun 17, 2026
Gunderson Thomas J. Director 2 operations $2.21 0 0 Jun 15, 2026 Jun 17, 2026
Lovell Stephanie · Director Grant (A) 3K
Owned 6K Trade date May 20, 2026 Filed date May 22, 2026
Lovell Stephanie Director Grant (A) 3K 6K May 20, 2026 May 22, 2026
Weill David · Director Grant (A) 3K
Owned 15K Trade date May 20, 2026 Filed date May 22, 2026
Weill David Director Grant (A) 3K 15K May 20, 2026 May 22, 2026
Raines Merilee · Director Grant (A) 3K
Owned 7K Trade date May 20, 2026 Filed date May 22, 2026
Raines Merilee Director Grant (A) 3K 7K May 20, 2026 May 22, 2026
Gunderson Thomas J. · Director Grant (A) 3K
Owned 7K Trade date May 20, 2026 Filed date May 22, 2026
Gunderson Thomas J. Director Grant (A) 3K 7K May 20, 2026 May 22, 2026
Basile Edward M. · Director Grant (A) 3K
Owned 6K Trade date May 20, 2026 Filed date May 22, 2026
Basile Edward M. Director Grant (A) 3K 6K May 20, 2026 May 22, 2026
Tobin James R. · Director Grant (A) 3K
Owned 7K Trade date May 20, 2026 Filed date May 22, 2026
Tobin James R. Director Grant (A) 3K 7K May 20, 2026 May 22, 2026
Kania Edwin · Director Grant (A) 3K
Owned 264K Trade date May 20, 2026 Filed date May 22, 2026
Kania Edwin Director Grant (A) 3K 264K May 20, 2026 May 22, 2026
Forsyth Matthew S. · Officer 2 operations 39K
Owned 23K Trade date May 19, 2026 Filed date May 21, 2026
Forsyth Matthew S. Officer 2 operations 39K 23K May 19, 2026 May 21, 2026
Lovell Stephanie · Director Sell −$178K
Price $149.62 Qty −1K Owned 3K Trade date Mar 4, 2026 Filed date Mar 6, 2026
Lovell Stephanie Director Sell $149.62 −1K −$178K 3K Mar 4, 2026 Mar 6, 2026
Weill David · Director Sell −$524K
Price $146.82 Qty −4K Owned 12K Trade date Mar 4, 2026 Filed date Mar 6, 2026
Weill David Director Sell $146.82 −4K −$524K 12K Mar 4, 2026 Mar 6, 2026
15 of 35
15 of 35 Sign in to continue to older insider transactions.

TransMedics Group, Inc. (TMDX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Blackrock, Inc. 5.3M
% of shares outstanding 15.9% Filing date Oct 7, 2024
Blackrock, Inc. 5.3M 15.9% Oct 7, 2024
Vanguard Group Inc 3.6M
% of shares outstanding 10.8% Filing date Oct 4, 2024
Vanguard Group Inc 3.6M 10.8% Oct 4, 2024
BlackRock Inc. 2.6M
% of shares outstanding 7.8% Filing date Jan 25, 2024
BlackRock Inc. 2.6M 7.8% Jan 25, 2024
FMR LLC 2.2M
% of shares outstanding 6.6% Filing date Oct 7, 2024
FMR LLC 2.2M 6.6% Oct 7, 2024
Vanguard Portfolio Management 1.9M
% of shares outstanding 5.7% Filing date Apr 29, 2026
Vanguard Portfolio Management 1.9M 5.7% Apr 29, 2026
Vanguard Capital Management 1.7M
% of shares outstanding 5.1% Filing date Apr 30, 2026
Vanguard Capital Management 1.7M 5.1% Apr 30, 2026
Macquarie Group Ltd 1.5M
% of shares outstanding 4.7% Filing date Feb 14, 2024
Macquarie Group Ltd 1.5M 4.7% Feb 14, 2024
Sandhill Capital Partners LLC 1.2M
% of shares outstanding 3.8% Filing date Feb 10, 2023
Sandhill Capital Partners LLC 1.2M 3.8% Feb 10, 2023
8 of 9

TransMedics Group, Inc. (TMDX) ownership FAQ

Who owns TMDX?

410 reporting institutions disclosed TMDX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.